DNA repair factor linked to breast cancer may also play a role in Alzheimer’s disease
November 30, 2015 - 4:06 PM
Mutant forms of breast cancer factor 1 (BRCA1) are associated with
breast and ovarian cancers but according to new findings, in the brain
the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
The results, published in Nature Communications, suggest that low
levels of BRCA1 protein in the brain may contribute to dementia. The
study was funded by the National Institutes of Health.
“It’s extremely interesting that one molecule can be critically
involved in two apparently opposing conditions: cancer, in which too
many cells are born and neurodegenerative disease, in which too many
brain cells die off,” said senior author Lennart Mucke, M.D., director
of the Gladstone Institute of Neurological Disease, San Francisco, and
the Joseph B. Martin Distinguished Professor of Neuroscience, and
professor of neurology at the University of California, San Francisco.
Dr. Mucke and his colleagues suspected that defects in DNA repair
mechanisms could contribute to cognitive decline in AD and focused their
studies on BRCA1. BRCA1 plays a key role in repairing deoxyribonucleic
acid (DNA), our genetic code. DNA is a double helix structure that is
made of two strands and resembles a twisted ladder. Occasionally, one or
both of the strands will develop breaks, which are fixed by DNA repair
proteins including BRCA1. This process is critical for cell survival
because if DNA is not repaired properly, the cell may die.
When Dr. Mucke’s group examined brains of patients who died with
Alzheimer’s, they discovered low levels of BRCA1. In addition, the
researchers found reductions of BRCA1 in the brains of mouse models of
Alzheimer’s. In fact, experimental reduction of BRCA1 levels in brains
of healthy mice made their brain cells shrink and become dysfunctional.
Dr. Mucke’s team also investigated the effects of BRCA1 on
cognition. After researchers reduced BRCA1 levels in the brains of
healthy mice, the animals developed problems with learning and memory.
Mouse models of Alzheimer’s showed even greater declines in learning and
memory following reductions of BRCA1. In addition, lowering BRCA1
caused increased DNA damage in the brains of Alzheimer’s mice.
One of the hallmarks of Alzheimer’s disease is accumulation of a
protein fragment known as beta-amyloid, which is toxic to brain cells
and can lead to neuronal death. Dr. Mucke’s team found that adding
amyloid beta to neurons in a dish lowered levels of BRCA1.
According to Dr. Mucke and his colleagues, the findings suggest that
accumulation of beta-amyloid lowers levels of BRCA1, which increases DNA
damage in brain cells and may contribute to dementia.
“An emerging theme in neurodegeneration research is that normal DNA
repair protects against damage that causes neurons to die in dementia
and related disorders. This study supports and strengthens that theme by
showing that beta-amyloid decreases the levels of the DNA repair gene
BRCA1, and at the same time inhibits the ability to form new memories,”
said Roderick Corriveau, Ph.D., program director at NIH’s National
Institute of Neurological Disorders and Stroke, which provided funding
for the study.
“The functions of BRCA1 in the brain remain to be fully elucidated,”
said Dr. Mucke, “but our findings suggest that it may play an important
role in supporting critical brain functions in both health and disease.”
Further research is necessary to determine whether BRCA1 may be a
potential therapeutic target for treating dementia, and whether BRCA1
mutations that lead to cancer also affect brain function.
You don't have permmission to comment, or comments have been turned off for this article.